Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$770,435
+$5,158 QoQ
Shares Held
4,916
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#709
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CFO4Life Group, LLC holds $7,374,448 across 8 Drug Manufacturers - General names. NVS ranks #3 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539 | $2,676,589 | |
| 2 | LLY |
ELI LILLY & Co
|
1,589 | $1,905,894 | |
| 3 | NVS |
Novartis AG
This page
|
4,916 | $770,435 | |
| 4 | AMGN |
Amgen Inc
|
1,340 | $485,240 | |
| 5 | ABBV |
AbbVie Inc.
|
1,745 | $439,111 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,156 | $398,729 | |
| 7 | PFE |
Pfizer Inc
|
15,403 | $370,904 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,549 | $327,546 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $770,435 | 4,916 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $765,277 | 5,010 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $787,099 | 5,709 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $730,583 | 5,697 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $671,726 | 5,551 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $667,653 | 5,989 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $644,094 | 6,619 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $717,724 | 6,240 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $567,644 | 5,332 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $619,652 | 6,406 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $708,304 | 7,015 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $728,400 | 7,151 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $632,201 | 6,265 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $528,264 | 5,742 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $582,513 | 6,421 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $422,311 | 5,556 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $462,632 | 5,473 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $494,208 | 5,632 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $509,775 | 5,828 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $505,563 | 6,182 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $531,746 | 5,828 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $500,228 | 5,852 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $534,473 | 5,660 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $492,193 | 5,660 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $513,908 | 5,884 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $479,611 | 5,817 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||